QIM
Quantitative Investment Management’s Ligand Pharmaceuticals LGND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-4,544
| Closed | -$596K | – | 484 |
|
|
2021
Q2 | $596K | Buy |
4,544
+2,056
| +83% | +$270K | 0.05% | 269 |
|
|
2021
Q1 | $379K | Buy |
+2,488
| New | +$379K | 0.03% | 379 |
|
|
2019
Q3 | – | Sell |
-17,892
| Closed | -$2.04M | – | 697 |
|
|
2019
Q2 | $2.04M | Buy |
+17,892
| New | +$2.04M | 0.08% | 285 |
|
|
2019
Q1 | – | Sell |
-16,200
| Closed | -$2.2M | – | 757 |
|
|
2018
Q4 | $2.2M | Buy |
+16,200
| New | +$2.2M | 0.11% | 175 |
|
|
2018
Q3 | – | Sell |
-7,800
| Closed | -$1.62M | – | 769 |
|
|
2018
Q2 | $1.62M | Sell |
7,800
-29,500
| -79% | -$6.11M | 0.03% | 405 |
|
|
2018
Q1 | $6.16M | Buy |
37,300
+16,700
| +81% | +$2.76M | 0.11% | 235 |
|
|
2017
Q4 | $2.82M | Sell |
20,600
-5,200
| -20% | -$712K | 0.04% | 433 |
|
|
2017
Q3 | $3.51M | Sell |
25,800
-19,400
| -43% | -$2.64M | 0.04% | 404 |
|
|
2017
Q2 | $5.49M | Buy |
+45,200
| New | +$5.49M | 0.08% | 310 |
|
|
2016
Q3 | – | Sell |
-18,800
| Closed | -$2.24M | – | 776 |
|
|
2016
Q2 | $2.24M | Buy |
18,800
+3,600
| +24% | +$429K | 0.1% | 266 |
|
|
2016
Q1 | $1.63M | Buy |
15,200
+11,000
| +262% | +$1.18M | 0.08% | 302 |
|
|
2015
Q4 | $455K | Sell |
4,200
-10,200
| -71% | -$1.11M | 0.03% | 514 |
|
|
2015
Q3 | $1.23M | Buy |
+14,400
| New | +$1.23M | 0.09% | 263 |
|
|
2015
Q2 | – | Sell |
-6,000
| Closed | -$462K | – | 595 |
|
|
2015
Q1 | $462K | Buy |
+6,000
| New | +$462K | 0.04% | 370 |
|